Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Cboe Europe  -  05:00 2022-09-26 am EDT
9982.50 GBX   -0.33%
04:47aGSK Names Burberry Executive Julie Brown New Finance Chief
MT
02:34aGSK PLC Names Julie Brown as New CFO; Iain Mackay to Retire in May
DJ
02:07aGSK picks Burberry's Brown as first female CFO
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ASTRAZENECA : Gets a Buy rating from Barclays

08/04/2022 | 07:50am EDT

In his latest research note, analyst Emily Field confirms his positive recommendation. The broker Barclays is keeping its Buy rating. The target price is being increased from GBX 12000 to GBX 12500.


© MarketScreener with dpa-AFX Analyser 2022
All news about ASTRAZENECA PLC
04:47aGSK Names Burberry Executive Julie Brown New Finance Chief
MT
02:34aGSK PLC Names Julie Brown as New CFO; Iain Mackay to Retire in May
DJ
02:07aGSK picks Burberry's Brown as first female CFO
RE
01:26aValneva in talks with potential partner on second-gen COVID-19 vaccines
RE
12:21aAstraZeneca Junks Ionis' Cholesterol Drug After Failing To Reach Efficacy Threshold In ..
MT
09/23ADRs End Lower, Alibaba and AstraZeneca Trade Actively
DJ
09/23Merck - LYNPARZA Approved in China as First-Line Maintenance Treatment with Bevacizumab..
AQ
09/23SECTOR UPDATE : Health Care Stocks Retreat Pre-Bell Friday
MT
09/23ETF PREVIEW : ETFs, Futures Plunge Pre-Bell Amid Global Central Bank Rate Decisions
MT
09/23SECTOR UPDATE : Health Care
MT
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 44 322 M - -
Net income 2022 4 574 M - -
Net Debt 2022 24 523 M - -
P/E ratio 2022 38,8x
Yield 2022 2,70%
Capitalization 170 B 170 B -
EV / Sales 2022 4,38x
EV / Sales 2023 4,06x
Nbr of Employees 83 100
Free-Float 96,5%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 109,50 $
Average target price 142,05 $
Spread / Average Target 29,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC15.42%169 672
JOHNSON & JOHNSON-2.54%438 337
ELI LILLY AND COMPANY12.76%295 941
ROCHE HOLDING AG-18.41%259 291
ABBVIE INC.5.66%252 944
PFIZER, INC.-25.35%247 392